Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President

PHILADELPHIA, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, today announced that Carolyn Bonner, currently President of the Company, has also been appointed Chief Financial Officer, effective immediately. Bonner has been serving as Acting Chief Financial Officer since September 12, 2025, in addition to her responsibilities as President, providing continuity and leadership during the medical leave of departing Chief Financial Officer Jim Quinlan, who has now formally resigned for health reasons.

Read more at globenewswire.com